WINDLAS BIOTECH LIMITED (WINDLAS) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid pharmaceutical dosage forms and provides a comprehensive range of CDMO services ranging from product discovery, product de…
Windlas Biotech Limited
WINDLAS
Market Cap₹1,752Cr.
Current Price₹849
High / Low₹1,098/697
Stock P/E26.4
Book Value₹275
Dividend Yield0.74%
ROCE15.9%
ROE12.2%
Face Value₹5.00
Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid pharmaceutical dosage forms and provides a comprehensive range of CDMO services ranging from product discovery, product development, and commercial manufacturing of generic products, including complex generics.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 13:11:29